⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9272701 | 0.95 | — | — | |
| SCHEMBL31215418 | 0.90 | ALDH1A1 (0.30) | — | |
| SCHEMBL28001658 | 0.87 | — | — | |
| SCHEMBL9121199 | 0.85 | — | — | |
| SCHEMBL28028349 | 0.85 | — | — | |
| SCHEMBL29941995 | 0.85 | — | — | |
| SCHEMBL1089492 | 0.82 | — | — | |
| SCHEMBL40810 | 0.72 | ALDH1A1 (0.43) | — | |
| SCHEMBL3073379 | 0.72 | ALDH1A1 (0.43) | — | |
| SCHEMBL3079047 | 0.72 | ALDH1A1 (0.43) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024022332-A1 | FAP INHIBITORS | SHANGHAI SINOTAU BIOTECH. CO., LTD (CN) | 2024-02-01 | — | — | WO | claimed |
| WO-2023202655-A1 | FAP INHIBITORS | SHANGHAI SINOTAU BIOTECH. CO., LTD (CN) | 2023-10-26 | — | — | WO | claimed |
| WO-2024149345-A1 | LINKERS, DRUG LINKERS AND CONJUGATES THEREOF AND METHODS OF USING THE SAME | PROFOUNDBIO US CO. (US) | 2024-07-18 | — | — | WO | disclosed |
| EP-4366777-A2 | LINKERS, DRUG LINKERS AND CONJUGATES THEREOF AND METHODS OF USING THE SAME | PROFOUNDBIO US CO. (US) | 2024-05-15 | — | — | EP | disclosed |
| WO-2024037635-A1 | A TRIFUNCTIONAL COMPOUND AND USE THEREOF | BOOMRAY PHARMACEUTICALS (BEIJING) CORPORATION LIMITED (CN) | 2024-02-22 | — | — | WO | disclosed |
| WO-2024022332-A1 | FAP INHIBITORS | SHANGHAI SINOTAU BIOTECH. CO., LTD (CN) | 2024-02-01 | — | — | WO | disclosed |
| WO-2023202655-A1 | FAP INHIBITORS | SHANGHAI SINOTAU BIOTECH. CO., LTD (CN) | 2023-10-26 | — | — | WO | disclosed |
| WO-2023143559-A1 | TFPI BINDING POLYPEPTIDES AND USES THEREOF | Westlake University (CN) | 2023-08-03 | — | — | WO | disclosed |
| WO-2023088481-A1 | ANTIBODY SPECIFIC TO EPHRIN TYPE-A RECEPTOR 10, FUSION PROTEIN CONTAINING THE SAME, CHIMERIC ANTIGEN RECEPTOR T-CELL EXPRESSING THE SAME AND USES THEREOF | CHINA MEDICAL UNIVERSITY (CN) | 2023-05-25 | — | — | WO | disclosed |
| WO-2023088482-A1 | ANTIBODY MONO-OR MULTI-SPECIFIC TO EPHRIN TYPE-A RECEPTOR 10, CHIMERIC ANTIGEN RECEPTOR T-CELL EXPRESSING THE SAME AND USES THEREOF | CHINA MEDICAL UNIVERSITY (CN) | 2023-05-25 | — | — | WO | disclosed |
| WO-2023088483-A1 | ANTIBODY SPECIFIC TO EPHRIN TYPE-A RECEPTOR 10, CHIMERIC ANTIGEN RECEPTOR T-CELL EXPRESSING THE SAME AND USES THEREOF | CHINA MEDICAL UNIVERSITY (CN) | 2023-05-25 | — | — | WO | disclosed |
| WO-2023025214-A1 | HETERODIMERIC IMMUNOGLOBULINS | GUANGZHOU LINTONPHARM CO., LTD. (CN) | 2023-03-02 | — | — | WO | disclosed |
| WO-2023280227-A2 | LINKERS, DRUG LINKERS AND CONJUGATES THEREOF AND METHODS OF USING THE SAME | PROFOUNDBIO US CO. (US) | 2023-01-12 | — | — | WO | disclosed |
| EP-2473195-A2 | GASTRIC RETENTIVE PHARMACEUTICAL COMPOSITIONS FOR IMMEDIATE AND EXTENDED RELEASE OF ACETAMINOPHEN | Depomed, Inc. (US) | 2012-07-11 | — | — | EP | disclosed |
| WO-2011026125-A2 | GASTRIC RETENTIVE PHARMACEUTICAL COMPOSITIONS FOR IMMEDIATE AND EXTENDED RELEASE OF ACETAMINOPHEN | DEPOMED, INC. (US) | 2011-03-03 | — | — | WO | disclosed |
| WO-2003007881-A2 | ANTIBODIES SPECIFIC FOR NANOTUBES AND RELATED METHODS AND COMPOSITIONS | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 2003-01-30 | — | — | WO | disclosed |
| EP-1245031-A1 | METHOD OF PRODUCING ACTINIUM-225 AND DAUGHTERS | Schenter, Scott (US) | 2002-10-02 | — | — | EP | disclosed |
| WO-2001041154-A1 | METHOD OF PRODUCING ACTINIUM-225 AND DAUGHTERS | SCHENTER SCOTT (US) | 2001-06-07 | — | — | WO | disclosed |
| WO-1995026206-A1 | METHOD FOR PREPARING RADIONUCLIDE-LABELED CHELATING AGENT-LIGAND COMPLEXES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1995-10-05 | — | — | WO | disclosed |